[{"NetIncomeLoss_3_Q3_USD":-237300000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":8000000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":97900000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_3_Q3_USD":4554200000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":200000.0,"InventoryRawMaterialsAndSupplies_0_Q3_USD":167000000.0,"SaleAndLeasebackTransactionGainLossNet_3_Q3_USD":45600000.0,"AssetsCurrent_0_Q3_USD":3281400000.0,"ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_1_Q3_USD":20800000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-4705900000.0,"PaymentsForRestructuring_3_Q3_USD":16200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-121800000.0,"InventoryFinishedGoods_0_Q3_USD":797100000.0,"IncreaseDecreaseInOperatingCapital_3_Q3_USD":-290900000.0,"RestrictedCashCurrent_0_Q3_USD":10700000.0,"CommitmentsAndContingencies_0_Q3_USD":0.0,"ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_3_Q3_USD":20800000.0,"LongTermDebt_0_Q3_USD":6140100000.0,"RestructuringSettlementAndImpairmentProvisions_3_Q3_USD":456400000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q3_USD":262200000.0,"ShareBasedCompensation_3_Q3_USD":31100000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":93000000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":51900000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0_Q3_USD":4711100000.0,"Assets_0_Q3_USD":17237000000.0,"PaymentsForSoftware_3_Q3_USD":147800000.0,"CommonStockSharesIssued_0_Q3_shares":471879904.0,"OperatingLeaseLeaseIncomeLeasePayments_3_Q3_USD":27800000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":11300000.0,"GainLossOnSaleOfOtherAssets_3_Q3_USD":51300000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":441800000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":1070400000.0,"ContractWithCustomerLiability_0_Q3_USD":150600000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":277700000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":622500000.0,"RestructuringCharges_3_Q3_USD":132600000.0,"LongTermDebtCurrent_0_Q3_USD":553600000.0,"InventoryGross_0_Q3_USD":1628200000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":567600000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":40300000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q3_USD":-28000000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-74000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-116600000.0,"AccountsReceivableNetCurrent_0_Q3_USD":762300000.0,"InventoryLIFOReserve_0_Q3_USD":31100000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q3_USD":900000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_3_Q3_USD":3200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":462400000.0,"CommonStockValue_0_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":426500000.0,"RepaymentsOfLongTermLinesOfCredit_3_Q3_USD":684200000.0,"NumberOfCountriesInWhichEntityOperates_0_Q3_country":90.0,"EarningsPerShareBasic_1_Q3_USD":-0.29,"EarningsPerShareBasic_3_Q3_USD":-0.56,"DeferredFinanceCostsGross_0_Q3_USD":90200000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":88100000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":214300000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":7300000.0,"ProceedsFromIssuanceOrSaleOfEquity_3_Q3_USD":1219900000.0,"OtherReceivablesNetCurrent_0_Q3_USD":70800000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":294700000.0,"Liabilities_0_Q3_USD":8892800000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":659900000.0,"OtherAssetsNoncurrent_0_Q3_USD":492800000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":95600000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":196200000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-42000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-185400000.0,"GainLossOnSaleOfBusiness_3_Q3_USD":169700000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q3_USD":101100000.0,"CostsAndExpenses_1_Q3_USD":1098600000.0,"CostsAndExpenses_3_Q3_USD":2487500000.0,"ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_3_Q3_USD":434700000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q3_USD":131100000.0,"BusinessCombinationIntegrationRelatedCosts_3_Q3_USD":318500000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":4972200000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.329,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.354,"EquityMethodInvestments_0_Q3_USD":21700000.0,"LitigationReserve_0_Q3_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":5001300000.0,"BusinessExitCosts1_3_Q3_USD":700000.0,"NonoperatingIncomeExpense_3_Q3_USD":161700000.0,"RestructuringReserveAccrualAdjustment1_3_Q3_USD":-800000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":102500000.0,"AccountsPayableCurrent_0_Q3_USD":355900000.0,"LiabilitiesCurrent_0_Q3_USD":1871200000.0,"GainLossOnDispositionOfAssets_1_Q3_USD":0.0,"GainLossOnDispositionOfAssets_3_Q3_USD":3800000.0,"NonoperatingIncomeExpense_1_Q3_USD":114900000.0,"InventoryWorkInProcess_0_Q3_USD":664100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":426500000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":51900000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":101200000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":121500000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":11700000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_3_Q3_USD":3500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":462400000.0,"InterestExpense_3_Q3_USD":89400000.0,"InterestExpense_1_Q3_USD":48100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":670600000.0,"NetIncomeLoss_1_Q3_USD":-135000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1242500000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-15200000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q3_USD":-2200000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3_Q3_USD":-19600000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":823100000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":68000000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NoncurrentAssets_0_Q3_USD":1665700000.0,"AdditionalPaidInCapital_0_Q3_USD":8620400000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q3_USD":39900000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":5785600000.0,"LongTermDebtNoncurrent_0_Q3_USD":5586500000.0,"SeveranceCosts1_1_Q3_USD":130200000.0,"SeveranceCosts1_3_Q3_USD":131200000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":180600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-209000000.0,"DeferredFinanceCostsNet_0_Q3_USD":101500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-353900000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":16800000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":17237000000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-159800000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q3_USD":0.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3_Q3_USD":-3100000.0,"PreferredStockValue_0_Q3_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":278600000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q3_USD":700000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":139900000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3_Q3_USD":2200000.0,"InventoryNet_0_Q3_USD":1597100000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q3_USD":-7500000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3_Q3_USD":-67400000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":889600000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":2133600000.0,"CommonStockSharesAuthorized_0_Q3_shares":5000000000.0,"BusinessExitCosts1_1_Q3_USD":0.0,"RestructuringReserve_0_Q3_USD":136500000.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":797500000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":312900000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":48600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":982700000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":86400000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":212000000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.29,"EarningsPerShareDiluted_3_Q3_USD":-0.56,"CommonStockSharesOutstanding_0_Q3_shares":471879904.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":325500000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-154400000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q3_USD":299100000.0,"ProceedsFromHedgeInvestingActivities_3_Q3_USD":32700000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":8800000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":6241200000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":16200000.0,"StockholdersEquity_0_Q3_USD":8344200000.0,"GoodwillAcquiredDuringPeriod_3_Q3_USD":3327300000.0,"OtherLiabilitiesCurrent_0_Q3_USD":531900000.0,"Goodwill_0_Q3_USD":6434700000.0,"GoodwillPurchaseAccountingAdjustments_3_Q3_USD":19900000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201106"}]